EpiAxis Therapeutics announces new Board member

EpiAxis Therapeutics announces new Board member

EpiAxis Therapeutics is pleased to announce the appointment of Rob McInnes as a non-executive director to the EpiAxis Board, following a successful fund raise supported by Sydney Angels. McInnes is one of Australia’s leading biotech IP specialists having initially...
EpiAxis expands Phase 1 metastic breast cancer trial

EpiAxis expands Phase 1 metastic breast cancer trial

EpiAxis Therapeutics has expanded its clinical trial program to include two additional recruitment centres for its Phase 1b metastatic breast cancer program. The centres open for patient recruitment are the Southern Medical Day Care Centre in Wollongong and at the...